BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 16204725)

  • 1. Abnormal regional brain function in Parkinson's disease: truth or fiction?
    Ma Y; Tang C; Moeller JR; Eidelberg D
    Neuroimage; 2009 Apr; 45(2):260-6. PubMed ID: 18992824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROI and phobias: The effect of ROI approach on an ALE meta-analysis of specific phobias.
    Gentili C; Messerotti Benvenuti S; Lettieri G; Costa C; Cecchetti L
    Hum Brain Mapp; 2019 Apr; 40(6):1814-1828. PubMed ID: 30548734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of Centiloids for applying [
    Tudorascu DL; Minhas DS; Lao PJ; Betthauser TJ; Yu Z; Laymon CM; Lopresti BJ; Mathis CA; Klunk WE; Handen BL; Christian BT; Cohen AD
    Alzheimers Dement (Amst); 2018; 10():332-339. PubMed ID: 30014032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalent latitude computation using regions of interest (ROI).
    Añel JA; Allen DR; Sáenz G; Gimeno L; de la Torre L
    PLoS One; 2013; 8(9):e72970. PubMed ID: 24086267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using
    Beauchamp LC; Dore V; Villemagne VL; Xu S; Finkelstein D; Barnham KJ; Rowe C
    Neurology; 2023 Nov; 101(22):e2314-e2324. PubMed ID: 37816639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An automatic analysis framework for FDOPA PET neuroimaging.
    Nordio G; Easmin R; Giacomel A; Dipasquale O; Martins D; Williams S; Turkheimer F; Howes O; Veronese M; ; Jauhar S; Rogdaki M; McCutcheon R; Kaar S; Vano L; Rutigliano G; Angelescu I; Borgan F; D'Ambrosio E; Dahoun T; Kim E; Kim S; Bloomfield M; Egerton A; Demjaha A; Bonoldi I; Nosarti C; Maccabe J; McGuire P; Matthews J; Talbot PS
    J Cereb Blood Flow Metab; 2023 Aug; 43(8):1285-1300. PubMed ID: 37026455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensitivity and specificity of F-DOPA PET in a movement disorder clinic.
    Ibrahim N; Kusmirek J; Struck AF; Floberg JM; Perlman SB; Gallagher C; Hall LT
    Am J Nucl Med Mol Imaging; 2016; 6(1):102-9. PubMed ID: 27069770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (18)F-DOPA PET with and without MRI fusion, a receiver operator characteristics comparison.
    Struck AF; Hall LT; Kusmirek JE; Gallagher CL; Floberg JM; Jaskowiak CJ; Perlman SB
    Am J Nucl Med Mol Imaging; 2012; 2(4):475-82. PubMed ID: 23145363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches.
    Kumakura Y; Cumming P
    Neuroscientist; 2009 Dec; 15(6):635-50. PubMed ID: 19793723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Imaging in Parkinson Disease.
    Meles SK; Teune LK; de Jong BM; Dierckx RA; Leenders KL
    J Nucl Med; 2017 Jan; 58(1):23-28. PubMed ID: 27879372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving influx constant and ratio estimation in FDOPA brain PET analysis for Parkinson's disease.
    Pan XB; Wright TG; Leong FJ; McLaughlin RA; Declerck JM; Silverman DH
    J Nucl Med; 2005 Oct; 46(10):1737-44. PubMed ID: 16204725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation-based partial volume correction for dopaminergic PET imaging: Impact of segmentation accuracy.
    Rong Y; Vernaleken I; Winz OH; Goedicke A; Mottaghy FM; Kops ER
    Z Med Phys; 2015 Sep; 25(3):230-42. PubMed ID: 25172832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDOPA kinetics in brain tumors.
    Schiepers C; Chen W; Cloughesy T; Dahlbom M; Huang SC
    J Nucl Med; 2007 Oct; 48(10):1651-61. PubMed ID: 17873130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.
    Whone AL; Bailey DL; Remy P; Pavese N; Brooks DJ
    J Nucl Med; 2004 Jul; 45(7):1135-45. PubMed ID: 15235059
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.